Th17, Treg, IFN, TLR, NF-B Reporter Cell Lines for drug discovery screening

IMGENEX’s proprietary Reporter Cell Lines provide the most advanced system available for screening Treg, Th17, TLR, STAT3 and inflammatory pathway mediators.
Register for free to listen to this article
Listen with Speechify
0:00
1:00

IMGENEX Corp.
IMGENEX's proprietary Reporter Cell Lines provide the mostadvanced system available for screening Treg, Th17, TLR, STAT3 and inflammatorypathway mediators. New and unique LUCPorter Stable Reporter Cell lines includepromoters for IL-17A, ROR, ROR(t), FoxP3, IL-8, TLR3/IFN, STAT3, Ap-1 andCXCL2 as targets driving Renilla Luciferase reporter gene expression.
IMGENEX Corp.
info@imgenex.com

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Fluorescent-style illustration of spherical embryonic stem cells clustered together against a dark background.
Explore how emerging in vitro systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes. 
3D illustration of ciliated cells, with cilia shown in blue.
Ultraprecise proteomic analysis reveals new insights into the molecular machinery of cilia.
3D illustration showing a DNA double helix encapsulated in a transparent capsule, surrounded by abstract white and orange protein-like molecular structures against a blue background.
Discover an integrated analytical approach that unites identification, purification, and stability assessment for therapeutic molecules.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue